Vancouver, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company“), welcomes the continued expansion of U.S. government efforts to map and characterize offshore areas with potential critical mineral resources.

On September 24, 2026, the National Oceanic and Atmospheric Administration (“NOAA”) commenced an additional mapping expedition aboard NOAA ship Okeanos Explorer focused on unexplored deepwater regions near American Samoa.1 The expedition follows NOAA’s recently completed American Samoa ROV and Mapping Exploration, which concluded on September 17, 2026, and is intended to fill remaining gaps in seafloor mapping before the vessel transits to Hawaii.2

The recent expeditions form part of broader U.S. government efforts to improve scientific understanding of marine critical mineral resources and deep ocean environments.3,4 NOAA’s 2026 work in the region has included multibeam seafloor mapping, remotely operated vehicle exploration, geological observations and environmental data collection, including the examination of areas containing polymetallic nodules.2

“While this recent mapping program by NOAA is focused on the U.S. Exclusive Economic Zone, we view it as part of a broader U.S. government effort to advance the scientific, regulatory and strategic framework for seabed critical minerals,” said James Deckelman, Chief Executive Officer of Deep Sea Minerals. “That broader effort is relevant to Deep Sea Minerals as we pursue our NOAA pathway in international waters and evaluate opportunities in Pacific jurisdictions, including the Cook Islands. Continued investment in seabed mapping, environmental data and resource characterization helps build the knowledge base needed to support responsible development of the sector.”

Polymetallic nodules can contain commercially important concentrations of minerals such as nickel, cobalt, copper and manganese, which are used across a range of industrial, energy, infrastructure and defense applications.4,5

The United States has increasingly emphasized the importance of expanding domestic and allied sources of critical minerals,4 while federal agencies continue to advance regulatory, scientific and mapping initiatives related to offshore mineral resources.3,4

Deep Sea Minerals Corp. is advancing its strategy focused on the exploration and potential development of polymetallic nodule resources. Through its U.S. subsidiary, American Deep Sea Minerals Corp., the Company has submitted an application to NOAA under the Deep Seabed Hard Mineral Resources Act (“DSHMRA”) for an exploration license covering areas of the Clarion-Clipperton Zone in international waters (the “NOAA Application”). While the Company believes that the NOAA Application will be determined to be in full compliance with applicable regulations and continue to progress through the regulatory review and approval process under the DSHMRA, there can be no assurance that NOAA will determine the NOAA Application to be in full compliance or that NOAA will ultimately issue an exploration license on terms acceptable to the Company or at all. For further information regarding the NOAA Application and the regulatory review and approval process under the DSHMRA, see the Company’s amended and restated annual information form for the financial year ended December 31, 2025, dated July 27, 2026 (the “A&R AIF”), a copy of which is available under the Company’s profile at www.sedarplus.ca. 

SOURCES

  1. National Oceanic and Atmospheric Administration, 2026 American Samoa Mapping + Transit (EX2607), NOAA Ocean Exploration:  https://oceanexplorer.noaa.gov/expedition/ex2607/
  1. National Oceanic and Atmospheric Administration, 2026 American Samoa ROV + Mapping Exploration (EX2606), NOAA Ocean Exploration: https://oceanexplorer.noaa.gov/expedition/ex2606/
  1. National Oceanic and Atmospheric Administration, Mapping the Seafloor for Critical Mineral Resources, NOAA Ocean Service: https://oceanservice.noaa.gov/deep-seabed-mineral-resources/mapping.html
  1. The White House, Executive Order 14285 – Unleashing America’s Offshore Critical Minerals and Resources, April 24, 2025: https://www.whitehouse.gov/presidential-actions/2025/04/unleashing-americas-offshore-critical-minerals-and-resources/
  1. U.S. Geological Survey, Deep-Ocean Polymetallic Nodules and Cobalt-Rich Ferromanganese Crusts in the Global Ocean: https://www.usgs.gov/publications/deep-ocean-polymetallic-nodules-and-cobalt-rich-ferromanganese-crusts-global-ocean-new

ABOUT DEEP SEA MINERALS CORP.

Deep Sea Minerals Corp. is a seabed mineral exploration and development company focused on evaluating opportunities to support the future supply of critical minerals through the acquisition, exploration, and development of deep-sea mineral assets.

The Company’s strategy is centered on identifying jurisdictions and geological settings with potential exposure to polymetallic nodule systems, which are recognized for containing combinations of metals that may be relevant to defense, industrial manufacturing, clean energy infrastructure, advanced electronics, and artificial intelligence-related supply chains. These seabed resources represent a largely undeveloped component of the global mineral supply base and are the subject of increasing policy, scientific, and regulatory attention worldwide.

As part of this process, the Company has commenced early-stage engagement with selected governments and regulatory bodies in the Pacific Ocean region to assess potential pathways for future exploration initiatives, subject to applicable international, national, and environmental frameworks.

For further information, please see the Company’s website: https://www.deepseamineralscorp.com

SOCIAL MEDIA

Facebook: https://www.facebook.com/deepseacorp/
Instagram: https://www.instagram.com/deepseacorp
X: https://x.com/deepseacorp
LinkedIn: https://www.linkedin.com/company/deepseacorp
Youtube: https://www.youtube.com/@deepseacorp

ON BEHALF OF THE BOARD

“James A. Deckelman”
James A. Deckelman, Chief Executive Officer

For further information, please contact:

James A. Deckelman
Chief Executive Officer
Phone: 1-281-467-1279
Email: info@deepseamineralscorp.com

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved the contents of this press release.

Forward-Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively, “forward-looking statements”) that relate to the Company’s current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “may”, “might”, “will”, “expect”, “anticipate”, “estimate”, “intend”, “plan”, “indicate”, “seek”, “believe”, “predict” or “likely”, or the negative or grammatical variations of these terms, or other similar expressions intended to identify forward-looking statements, although not all forward-looking statements include such words. The Company has based these forward-looking statements on its current expectations and projections about future events and financial trends that it believes might affect its financial condition, results of operations, business, prospects and financial needs. Forward-looking statements contained in this news release include, but are not limited to, statements about: the Company’s plans and strategies, including the potential acquisition of subsea mineral exploration or exploitation rights; NOAA determining the NOAA Application to be in full compliance; and NOAA granting an exploration license to the Company.

This forward-looking information and other forward-looking information are based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Material factors underlying forward-looking information and management’s expectations include certain assumptions in respect of, among other things: favourability of operating conditions; the receipt of necessary third party approvals, licences or permits on favourable terms; the result of any potential legal, regulatory or geopolitical conflict resulting from the United States asserting governance of subsea mineral exploration and development in international waters under the DSHMRA; the availability of equipment; the availability of qualified vessel operators and marine contractors; our ability to obtain financing on acceptable terms; currency exchange and interest rates; the impact of competition; the changes and trends in our industry and the global economy; changes in laws, rules, regulations and global standards; our ability to build our market share; our ability to retain key personnel; transaction opportunities, exploration potential, and precious metals prices; the sufficiency of the NOAA Application under DSHMRA, submitted on July 17, 2026, in responding to the requests for supplemental information in NOAA’s notice to the Company dated May 26, 2026; that NOAA will require no further information from the Company in order to determine the NOAA Application is in full compliance with applicable regulatory requirements; that the federal-agency consultation, antitrust review, public-comment, certification, environmental-review and hearing processes applicable to the NOAA Application will proceed generally in accordance with the indicative regulatory periods described in the A&R AIF; that NOAA will not identify material deficiencies relating to the Company’s financial responsibility, technical capability, proposed exploration plan, environmental information, proposed licence area or other regulatory requirements that the Company is unable to address;  the continued cooperation and alignment of national interests between the United States and the Cook Islands; the Cook Islands’ intention to grant mining licenses in the future; that a licensing process or invitation will be available under the Cook Islands seabed minerals regime on terms allowing the Company to submit an application for an exploration licence in the exclusive economic zone of the Cook Islands (the “Cook Islands Application”); that the Company will be able to complete the technical, financial, environmental, corporate and work-program materials required for the Cook Islands Application within its anticipated timeframe; that the Company will be able to demonstrate access to sufficient financial resources, technical expertise, vessels, equipment, contractors and environmental capabilities to satisfy the applicable NOAA and Cook Islands regulatory requirements; that the Company will obtain sufficient financing to fund the regulatory, environmental, technical and offshore activities contemplated by its NOAA and Cook Islands work programs when required; the Cook Islands authorities will designate additional parcel blocks or areas for subsea mineral exploration and exploitation; and NOAA’s mapping program in Exclusive Economic Zones of the United States and other U.S. government efforts reflect a sincere intention of the United States government to advance subsea mineral exploration and exploitation in international waters under the DSHMRA regulatory pathway.

The forward-looking information in this news release is necessarily based on a number of opinions, estimates and assumptions that we considered appropriate and reasonable as of the date of the A&R AIF. It is also subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the risk factors and uncertainties described under “Risk Factors” in the A&R AIF, as well as risks related to the highly speculative nature of the Company’s business;  risks related to subsea mineral exploration and development operations; risks related to the Company’s limited business history and no history of earnings; risks related to the availability of future financing and the Company’s ability to continue as a going concern; risks related to the Company’s exploration and development activities on the mineral properties; uncertainties regarding the grade and quality of polymetallic nodules; uncertainties regarding the commercial collection of polymetallic nodules; negative perceptions regarding the collection of polymetallic nodules; pressure and lobbying by non-governmental organizations; uncertainties regarding our future reliance on strategic partnerships; uncertainties regarding technology required for our business; uncertainties regarding the treatment and processing of polymetallic nodules; natural hazards and seasonality; expropriation of potential future operating equipment or assets; technological obsolescence; the Company’s dependence on key personnel; risks related to foreign operations; risks related to acquisitions and integration; changes in laws and regulations; risks related to competition; fluctuations in prices of critical minerals, base and precious metals, other commodities and natural resources; legal and litigation risks; uncertainty and volatility related to stock market prices and conditions; dilution of the interests of shareholders; risks related to geopolitical disputes; risks related to the Company’s officers and directors becoming associated with other natural resource companies, which may give rise to conflicts of interest; risks related to climate change; and risks related to pandemics, epidemics or other health crises. With respect to the specific matters addressed in this news release, additional risks and uncertainties include: the risk that NOAA will not determine the NOAA Application to be in full compliance, will not preserve the Company’s priority of right, or will not issue an exploration licence on acceptable terms or at all; the risk that the Company will be unable to demonstrate sufficient financial resources, technical expertise, vessels, equipment, contractors or environmental capabilities to satisfy applicable regulatory requirements; the risk that the Company will be unable to obtain sufficient financing to fund its planned regulatory, environmental, technical and offshore activities; the risk that the Company’s intended offshore operations will be delayed or prevented by regulatory, operational, environmental, financial or other factors; and risks relating to changes in laws, rules, regulations and global standards; and the risk that the Cook Islands Application will not be submitted within the anticipated timeframe, will not be accepted as complete, or will not be approved;. If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. The risks, uncertainties, opinions, estimates and assumptions referred to above and described in greater detail under “Risk Factors” in the A&R AIF should be considered carefully by readers.

Although we have attempted to identify important risk factors that could cause actual results or future events to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date of this news release. The forward-looking information contained in this news release represents our expectations as of the date of this news release (or as of the date they are otherwise stated to be made) and is subject to change after such date. We disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities legislation. 

Jena, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development, effective October 1, 2026.

Dr. Alperovich is a physician-scientist and nephrologist with more than two decades of experience in the global pharmaceutical industry, spanning senior leadership roles across clinical development and medical affairs, and a track record of advancing Phase 2 and registrational programs in immune-inflammatory renal diseases through to regulatory submission and approval.

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We are delighted to welcome Gabriela to our team. She brings deep clinical development expertise in immune-inflammatory diseases, a strong record of registrational and regulatory success, and hands-on experience leading global programs and teams. Her background in renal and complement-driven diseases is highly complementary to our efforts, and her leadership will be invaluable as we advance izicopan into its next phase of development and continue to build long-term value across our pipeline.”

Dr. Gabriela Alperovich commented: “I am excited to join InflaRx at such a pivotal moment for the Company and its complement-targeted platform. Throughout my career, I have focused on immune-inflammatory diseases, including renal diseases such as IgA nephropathy, lupus nephritis, or ANCA-associated vasculitis, where modulating the complement system can be truly disease-modifying for patients. InflaRx’s differentiated approach to C5a and C5aR inhibition, together with the best-in-class potential emerging for izicopan, represents a compelling opportunity to bring meaningful new therapies to patients with high unmet need. I look forward to working with the dedicated team at InflaRx to advance these programs.”

Dr. Alperovich joins InflaRx from CSL Vifor, where she served most recently as Executive Director, Global Clinical Lead for Cardiovascular and Renal, overseeing the company’s cardiovascular and renal clinical development programs and leading a global team of physicians and clinical scientists. Over more than 20 years in the industry, she has held clinical development and medical affairs leadership roles at CSL Vifor, AbbVie and Bristol-Myers Squibb, among others, leading Phase 2/3 registrational programs across multiple indications – including IgA nephropathy, focal segmental glomerulosclerosis (FSGS) and kidney transplant – with successful regulatory submissions and approvals, and taking direct responsibility for assets through lifecycle management and post-approval commitments. Dr. Alperovich is board certified in Internal Medicine and Nephrology and holds a PhD in kidney transplant from the University of Barcelona.

About izicopan

Izicopan is an orally administered, small molecule inhibitor of the C5a receptor (C5aR) that has shown anti-inflammatory therapeutic effects in several pre-clinical disease models and in human studies. InflaRx is planning for development of izicopan in ANCA-associated vasculitis (AAV) and additional renal indications.
Further, in contrast to the marketed C5aR inhibitor, in vitro experiments demonstrated that izicopan does not exhibit time-dependent inhibition of cytochrome P450 3A4 (CYP3A4), which plays an important role in the metabolism of a variety of metabolites and drugs, including glucocorticoids. Izicopan has also demonstrated a favorable reactive metabolite profile in human liver microsomes. Reported results from a first-in-human study demonstrated that izicopan was well tolerated in treated subjects and exhibited no safety signals of concern in single doses ranging from 3 mg to 240 mg or multiple doses ranging from 30 mg once per day to 90 mg twice per day for 14 days. Pharmacokinetic / pharmacodynamic data support the best-in-class potential of izicopan, with a ≥90% blockade of C5a-induced neutrophil activation achieved over the 14-day dosing period. Topline Phase 2a data further support the safety profile of izicopan, with no reported safety signals of concern. In patients with hidradenitis suppurativa, over 4 weeks of therapy, izicopan provided rapid and clinically meaningful reductions in abscesses and nodules and draining tunnels, robust HiSCR responses that continued to deepen four weeks after the treatment period, and substantial reductions in patient-reported pain scores, overall demonstrating the potential for biologic-like efficacy. In chronic spontaneous urticaria, InflaRx observed substantial reductions in the 7-day Urticaria Activity Score (UAS7) broadly across patients and particularly in those with severe disease, as well as improved disease control as measured by the Urticaria Control Test (UCT7).

About vilobelimab

Vilobelimab is a first-in-class monoclonal anti-human complement factor C5a antibody which highly and effectively blocks the biological activity of C5a and demonstrates high selectivity towards its target in human blood. Thus, vilobelimab leaves the formation of the membrane attack complex (C5b-9) intact as an important defense mechanism of the innate immune system, which is not the case for molecules blocking C5. In pre-clinical studies, vilobelimab has been shown to control the inflammatory response-driven tissue and organ damage by specifically blocking C5a as a key “amplifier” of this response. Vilobelimab has been evaluated in two controlled Phase 2 AAV studies, the European IXCHANGE trial and the U.S. IXPLORE trial.

About InflaRx N.V.

InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor, C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx‘s lead program is izicopan, an orally administered small molecule inhibitor of C5a-induced signaling via the C5a receptor, which has shown promising PK/PD characteristics as well as therapeutic potential in Phase 1 and Phase 2a clinical studies. The Company is developing izicopan for the treatment of ANCA-associated vasculitis and additional renal diseases. InflaRx also has developed vilobelimab, a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies.

InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA. For further information, please visit www.inflarx.de. Follow InflaRx on LinkedIn. InflaRx GmbH (Germany) and InflaRx Pharmaceuticals Inc. (USA) are wholly owned subsidiaries of InflaRx N.V. (together, InflaRx).

Contacts:

InflaRx N.V. MC Services AG
Jan Medina, CFA
Vice President, Head of Investor Relations
Email: IR@inflarx.de
Katja Arnold, Laurie Doyle, Dr. Regina Lutz
Email: inflarx@mc-services.eu
Europe: +49 89-210 2280
U.S.: +1-339-832-0752

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “estimate,” “believe,” “predict,” “potential” or “continue,” among others. Forward-looking statements appear in a number of places throughout this release and may include statements regarding our intentions, beliefs, projections, outlook, analyses and current expectations concerning, among other things, the success of our future clinical trials for izicopan’s treatment of AAV and other renal diseases, including aHUS, IgAN and C3G, and our ability to establish proof of concept for izicopan across such indications; the timing, progress and results of preclinical studies and clinical trials of vilobelimab, izicopan and any other of our product candidates; our interactions with regulators regarding the results of clinical trials and potential regulatory approval pathways, including potential regulatory paths in AAV for vilobelimab and izicopan and related discussions with EMA; the timing and outcome of any discussions or submission of filings for regulatory approval of vilobelimab, izicopan or any other product candidate, and the timing of and our ability to obtain and maintain full regulatory approval and/or marketing authorization for any indication; potential strategic transactions or collaborations, including a potential partnership of izicopan or vilobelimab for PG; whether the FDA, EMA or any comparable foreign regulatory authority will accept or agree with the number, design, size, conduct or implementation of our clinical trials, including any proposed primary or secondary endpoints for such trials; our ability to leverage our proprietary anti-C5a and anti-C5aR technologies to discover and develop therapies to treat complement-mediated immunological and inflammatory diseases; our ability to protect, maintain and enforce our intellectual property protection for vilobelimab, izicopan and any other product candidates, and the scope of such protection; our manufacturing capabilities and strategy, including the scalability and cost of our manufacturing methods and processes, the optimization of our manufacturing methods and processes, and our ability to rely on existing third-party manufacturers or engage additional third-party manufacturers for planned future clinical trials and commercial supply; our estimates of our expenses, ongoing losses, future revenue, capital requirements and our needs for or ability to obtain additional financing; our ability to defend against liability claims resulting from the testing of our product candidates in the clinic or, if approved or authorized, any commercial sales; if any of our product candidates obtain regulatory approval or authorization, our ability to comply with and satisfy ongoing drug regulatory obligations and continued regulatory oversight; our ability to comply with enacted and future legislation in seeking marketing approval, authorization or commercialization; our future growth and ability to compete, which depends on our retaining key personnel and recruiting additional qualified personnel; our competitive position and the development of and projections relating to our competitors in the development of C5a and C5aR inhibitors and other therapeutic products being developed in similar medical conditions in which vilobelimab, izicopan or any other of our product candidates is being developed or our industry; and the risks, uncertainties and other factors described under the heading “Risk Factors” in our periodic filings with the SEC. These statements speak only as of the date of this press release and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.

Milestone follows years of extensive operational diligence, comprehensive validation, and testing across high-volume commercial kitchens.

Approval builds on successful commercial rollout across brand locations announced on May 9, 2024, clearing the path for procurement across the parent company’s global franchise network.

VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried food while improving food quality, lowering operational costs, minimizing waste and enhancing sustainability, today announced a major commercial milestone in its ongoing relationship with one of the world’s largest multinational restaurant companies.

Building on the commercial rollout with the parent company’s brand announced on May 9, 2024, the multinational restaurant group has now added Beyond Oil to its global approved products list.

The parent company represents one of the largest restaurant enterprises in the world, with an extensive international footprint encompassing tens of thousands of restaurants across more than 100 countries and territories, generating tens of billions of dollars in annual system sales. Its brand portfolio includes some of the world’s most recognized and leading quick-service and fast-casual restaurants.

With global vendor approval now in place, Beyond Oil is part of the parent company’s approved products list, enabling the Company to begin working directly with franchise groups and regional operators across its global network.

The corporate approval follows extensive multi-year operational performance and evaluation, building on extensive initial diligence and pilot testing prior to the franchisee deployment in 2024. Over this period, Beyond Oil demonstrated consistent operational results in high-volume commercial kitchens, improving frying performance and oil management, reducing operating costs and waste, while maintaining high standards of food quality and safety.

The receipt of global approved vendor status immediately strengthens Beyond Oil’s international commercial pipeline. The Company is actively advancing discussions and onboarding processes with several large-scale regional franchise groups operating under the parent company’s brands across international jurisdictions, with initial franchise evaluations and commercial planning underway across multiple markets, including Europe and North America.

“Achieving approved vendor status with one of the world’s largest restaurant systems is a transformative commercial milestone for Beyond Oil,” said Jonathan Or, CEO of Beyond Oil. “This achievement follows years of operational validation, testing and relationship building across multiple markets, reflecting the operational consistency and product reliability required to operate within a global restaurant system of this scale. With approved vendor status now in place, we can begin working directly with franchise groups across a network spanning tens of thousands of locations worldwide, supported by the parent company’s corporate team. We believe this milestone marks the beginning of a defining new growth phase for Beyond Oil, translating years of proven operational validation into commercial scale across the global restaurant industry.”

About Beyond Oil Ltd.

We all love fried food. Let’s make it better. Not by changing what people love. By improving the system behind it. Beyond Oil Ltd. (TSX: BOIL, OTCQB: BEOLF) is a food-tech innovation company on a mission to help foodservice operators improve fried food across every dimension that matters: quality, health, consistency, safety, sustainability and profitability. We achieve these outcomes by improving the system behind every kitchen, the frying performance and oil management that determine what lands on the plate. The Company’s patented technology, cleared by the FDA and Health Canada, integrates into existing kitchen workflows to improve frying performance and oil management, helping operators deliver more consistent food, strengthen operational control and reduce oil waste. Beyond Oil’s solution serves restaurant chains, supermarkets, hotels, catering, institutions and industrial frying operations worldwide, turning frying into a measurable, repeatable and scalable brand standard. The result is a better frying standard, helping every fryer, every shift and every plate live up to the food people love. For more information, please visit: www.beyondoil.co.

Forward-Looking Statements and Information

This news release contains “forward-looking statements” within the meaning of the U.S. Securities Act of 1933, the U.S. Securities Exchange Act of 1934, “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of other relevant securities legislation, including applicable securities laws in Canada, which reflect Beyond Oil Ltd.’s current views with respect to, among other things, its operations and financial performance (collectively, “forward-looking statements”). Forward-looking statements include statements that are predictive in nature, depend upon or refer to future results, events or conditions, and include, but are not limited to, statements which reflect management’s current estimates, beliefs and assumptions and which are in turn based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. The estimates, beliefs and assumptions of Beyond Oil Ltd. are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions. In particular, this news release contains forward-looking statements regarding: the adoption and procurement of Beyond Oil across the parent company’s global franchise system and independent franchise partners; the timing, pace, and extent of franchisee onboarding and commercial deployment across international markets; the potential for Beyond Oil to become an established operating standard across quick-service restaurant networks; management’s expectations regarding international pipeline execution and commercial expansion; and ongoing discussions and evaluations with other restaurant chains and foodservice operators. Forward-looking statements are subject to specific risks and uncertainties, including that corporate approved vendor status authorizes, but does not guarantee, commercial adoption, deployment schedules, or minimum purchase order volumes by individual franchise partners; the negotiation, timing, and execution of definitive commercial agreements with regional franchisees; supply chain logistics, distribution, and local regulatory clearances across international jurisdictions; customer retention and re-order rates; and that ongoing discussions and evaluations with other restaurant chains may not lead to commercial agreements or system-wide approvals. Although Beyond Oil Ltd. believes that such forward-looking statements are based upon reasonable estimates, beliefs and assumptions, certain factors, risks and uncertainties, which are described from time to time in our documents filed with the securities regulators in the USA and Canada, as well as factors not presently known to Beyond Oil Ltd. or that Beyond Oil Ltd. currently believes are not material, could cause actual results to differ materially from those contemplated or implied by forward-looking statements. Readers are urged to consider these risks, as well as other uncertainties, factors and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements, which are based only on information available to us as of the date of this news release. Except as required by law, Beyond Oil Ltd. undertakes no obligation to publicly update or revise any forward-looking statements, whether written or oral, that may be as a result of new information, future events or otherwise.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Company Contact:
Adi Olesker, VP of Investor Relations
Phone: +972-50-694-2517
adio@beyondoil.co

Investor Relations Contact:
Arx Investor Relations
North American Equities Desk
BOIL@arxhq.com

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announced that, on September 30, 2026, the Constitutional Court of Bosnia and Herzegovina (the “Court”) published its full decision on the outcome of the constitutional dispute between Bosnia and Herzegovina and the Federation of Bosnia and Herzegovina concerning the authority of the Federation, cantonal and municipal bodies to adopt or enter into certain acts reflecting state-owned forests and forestry land, including the Concession Agreement and its annexes for the Vareš operation. The Court’s decision does not terminate or suspend the Concession Agreement or any of its annexes. DPM’s operations at Vareš continue to operate as normal.

The Court has set a period of six months for the relevant authorities, together with the Attorney General’s Office, to review the challenged acts and take the necessary steps to bring the matter into conformity and set aside those acts that are found to not comply with the Law on the Temporary Prohibition of Disposal of State Property. DPM intends to engage constructively with the Attorney General and the relevant authorities throughout this process.

This constitutional dispute relates to state owned forests and forest land in Bosnia and Herzegovina and forms part of a broader issue affecting a number of large concession-based investments in the country. The Court found that certain acts, including DPM’s Concession Agreement No. 04-18-21389-1/13 dated March 12, 2013 and Annexes I through VI, together with the related decisions of relevant authorities concerning forest land conversion and easement rights, were not in conformity with Articles I(2) and III(3)(b) of the Constitution of Bosnia and Herzegovina, as the relevant Federation, cantonal and municipal authorities did not have the authority to deal with such property contrary to the Law on the Temporary Prohibition of Disposal of State Property and without the involvement of Bosnia and Herzegovina and its Attorney General’s Office. The Court’s decision is final and not subject to appeal.

The Vareš operation employs more than 600 people from Bosnia and Herzegovina, has invested significantly in safety programs, training and leadership development, and is the top exporter in the Zenica-Doboj Canton.

About DPM Metals Inc.

DPM Metals Inc. is a Canadian-based international gold mining company with operations and projects located in Bulgaria, Bosnia and Herzegovina, Serbia and Ecuador. Our strategic objective is to become a mid-tier precious metals company, which is based on sustainable, responsible and efficient gold production from our portfolio, the development of quality assets, and maintaining a strong financial position to support growth in mineral reserves and production through disciplined strategic transactions. This strategy creates a platform for robust growth to deliver above-average returns for our shareholders. DPM trades on the Toronto Stock Exchange (symbol: DPM) and the Australian Securities Exchange as a Foreign Exempt Issuer (symbol: DPM).

For further information please contact:

Jennifer Cameron
Director, Investor Relations
Tel: (416) 219-6177
jcameron@dpmmetals.com

Cautionary Note Regarding Forward Looking Statements

This news release contains “forward looking statements” or “forward looking information” (collectively, “Forward Looking Statements”) that involve a number of risks and uncertainties. Forward Looking Statements are statements that are not historical facts and are generally, but not always, identified by the use of forward looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “outlook”, “intends”, “anticipates”, “believes”, or variations of such words and phrases or that state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions. The Forward Looking Statements in this news release relate to, among other things, the potential outcome of the review by authorities of its Concession Agreement; the Company’s intended next steps with respect to protect its rights in respect of the concession; the Company’s strategic objective and associated returns to shareholders, including DPM’s strategy to become a mid-tier precious metals Company. Forward Looking Statements are based on certain key assumptions and the opinions and estimates of management as of the date such statements are made, and they involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any other future results, performance or achievements expressed or implied by the Forward Looking Statements. In addition to factors already discussed in this news release, such factors include, among others, uncertainties with respect to the review by authorities and outcome of such review on DPM’s Concession Agreement; uncertainties with respect to DPM being successful in its engagement and next steps to protect its rights to the concession; fluctuations in metal prices and foreign exchange rates; risks arising from the current economic environment and the impact on operating costs and other financial metrics, including risks of recession; the speculative nature of mineral exploration, development and production, including changes in mineral production performance, exploitation and exploration results; changes in tax, tariff, and royalty regimes in the jurisdictions in which the Company operates, sells it concentrates. or which are otherwise applicable to the Company’s business, operations, or financial condition; possible inaccurate estimates relating to future production, operating costs and other costs for operations; possible variations in grade and recovery rates; inherent uncertainties in respect of conclusions of economic evaluations, economic studies and mine plans; the Company’s dependence on continually developing, replacing and expanding its mineral reserves; the ability of the Company to extend the Chelopech mine life; risks related to the possibility that future exploration results will not be consistent with the Company’s expectations, that quantities or grades of reserves will be diminished, and that resources may not be converted to reserves; risks related to the financial results of operations, changes in interest rates, and the Company’s ability to finance its operations; the impact of global liquidity and credit availability on the timing of cash flows and the values of assets and liabilities based on projected future cash flows; uncertainties inherent with conducting business in foreign jurisdictions where corruption, civil unrest, political instability and uncertainties with the rule of law may impact the Company’s activities; the effects of international economic and trade sanctions; accidents, labour disputes and other risks inherent to the mining industry; failure to achieve certain cost savings; risks related to the Company’s ability to manage environmental and social matters, including risks and obligations related to closure of the Company’s mining properties; risks related to climate change, including extreme weather events, resource shortages, emerging policies and increased regulations relating to related to greenhouse gas emission levels, energy efficiency and reporting of risks; the commencement, continuation or escalation of geopolitical crises and armed conflicts, including Iran and the broader Middle East region, and their direct and indirect effects on the operations of DPM; opposition by social and non-governmental organizations to mining projects; uncertainties with respect to realizing the anticipated benefits from the development of the Company’s exploration and development projects; cyber-attacks and other cybersecurity risks; competition in the mining industry; claims or litigation; limitations on insurance coverage; changes in laws and regulations applicable to the Company and its business operations, and judicial interpretations thereof; the Company’s ability to successfully obtain all necessary permits and other approvals required to conduct its operations; employee relations, including unionized and non-union employees, and the Company’s ability to retain key personnel and attract other highly skilled employees; unanticipated title disputes; volatility in the price of the common shares of the Company; potential dilution to the common shares of the Company; damage to the Company’s reputation due to the actual or perceived occurrence of any number of events, including negative publicity with respect to the Company’s handling of environmental matters or dealings with community groups, whether true or not; risks related to holding assets in foreign jurisdictions; as well as those risk factors discussed or referred to in any other documents (including without limitation the Company’s most recent Annual Information Form) filed from time to time with the securities regulatory authorities in all provinces and territories of Canada and available on SEDAR+ at www.sedarplus.ca. The reader has been cautioned that the foregoing list is not exhaustive of all factors which may have been used. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in Forward Looking Statements, there may be other factors that cause actions, events or results not to be anticipated, estimated or intended. There can be no assurance that Forward Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company’s Forward-Looking Statements reflect current expectations regarding future events and speak only as of the date hereof. Unless required by securities laws, the Company undertakes no obligation to update Forward Looking Statements if circumstances or management’s estimates or opinions should change. Accordingly, readers are cautioned not to place undue reliance on Forward Looking Statements.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader: Investec Bank Plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
SThree Plc
(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to SThree Plc
(d)        Date dealing undertaken: 30th September 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
        If it is a cash offer or possible cash offer, state “N/A”
N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary shares Purchase 2,000 306 304
Ordinary shares Sales 12,000 304.75 300

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
N/A N/A N/A N/A N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure: 01st October 2026
Contact name: Abhishek Gawde
Telephone number: +91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader: Investec Bank plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Pollen Street Group Limited
(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to Pollen Street Group Limited
(d)        Date dealing undertaken: 30th September 2026

(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
        If it is a cash offer or possible cash offer, state “N/A”
N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary shares Sales 440 923.22 923.22

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
N/A N/A N/A N/A N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

3.        OTHER INFORMATION
        
(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure: 01st October 2026
Contact name: Abhishek Gawde
Telephone number: +91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Vancouver, BC, Canada, Oct. 01, 2026 (GLOBE NEWSWIRE) — Big Bear Gold Corp. (TSXV: BEAR) (the “Company” or “BEAR”) is pleased to announce that it has entered into an assignment and assumption of property option agreement (the “Assignment Agreement”) dated September 25, 2026, with Bathurst Metals Corp. (TSXV: BMV) (“BMV”) and Stanley R McClay as bare trustee for BCT Holdings Corp. (the “Owner”), pursuant to which the Company will acquire BMV’s 100% optioned interest in the Peerless Property located in the Bridge River Mining Camp, British Columbia.

The Peerless Property encompasses 12 mineral claims covering 5,500.43 hectares. It has the same geological setting as surrounding mines and deposits where thrust faults and secondary faults cross anomalous zones, a classic setting for orogenic gold mineralization. It can be viewed as an intermediate orogenic gold system bridging the Bralorne and Reliance styles in Canada’s highest-grade historic gold district. It’s a compelling and underexplored project with five distinct gold zones already identified: beta, delta, gamma, alpha and epsilon. The project is drill ready with an active drill permit.  The project has year-round access with an extensive network of forestry roads crossing the property. Historical RC drilling from Manhatten Minerals in 1987 include 4.52 metres of 28.93 grams gold and 1.52 metres of 35.12 grams gold from the beta zone.

IMG_256
Please click to view image

Terms of the Assignment Agreement

Pursuant to the terms of the Assignment Agreement, BMV will sell and assign to the Company, and BEAR will acquire and assume, all of BMV‘s rights and interest in and obligations under a property option agreement between BMV and the Owner dated January 30, 2023, as amended October 10, 2025, and February 18, 2026 (the “Option Agreement”), in consideration for which BEAR will issue to BMV 3,555,000 common shares of the Company.  In addition, the parties have agreed that each will pay 50% of the cost of preparing an independent NI 43-101 compliant technical report on the Peerless Property.  BMV has also agreed to pay the Owner $25,000, which sum will be applied against and reduce the outstanding cash payment otherwise due to the Owner under the Option Agreement.  BMV and the Owner are arm’s length to BEAR.

After BMV’s payment to the Owner described above, the outstanding cash payments, expenditure commitments and share issuances due under the Property Option Agreement, in order to acquire a 100% interest in the Peerless Property, will be as follows:

  Cash
Payments
 
Expenditures
BEAR
Common Shares
June 30, 2027: $25,000.00 — 2,000,000
January 31, 2028: $50,000.00 — —
September 30, 2028 $75,000.00 $1,000,000.00 3,500,000
January 31, 2029 $100,000.00 — —
September 30, 2029 $100,000.00 $1,000,000.00 —
TOTAL: $350,000.00 $2,000,000.00 5,500,000

Pursuant to the Option Agreement, the acquisition of the Peerless Property is subject to a 2.5% net smelter returns royalty (“NSR Royalty”) in favour of the Owner, which in turn is subject to a buy-back right entitling the optionee thereunder to purchase a 1.0% NSR Royalty for $1,000,000 within 6 months of commencement of commercial production.

All shares issued in connection with this transaction will be subject to a hold period expiring four months and one day from their date of issuance.

Closing of the transactions contemplated by the Assignment Agreement is subject to the Company’s satisfactory due diligence on the Peerless Property within 90 days.  In addition, the Assignment Agreement, including the transactions contemplated thereunder, is subject to TSX Venture Exchange approval.

QP

The technical content of this news release has been reviewed and approved by Lorne Warner, a qualified person as defined by National Instrument 43-101. Lorne Warner also acts as President of Bathurst Metals Corp.

About Big Bear Gold Corp.

Big Bear Gold Corp. is focused on acquiring and developing mineral properties with strong potential to host significant resources in Western Canada. We are looking for additional projects that are in an established mining district with highly prospective geology that could host significant resources.

ON BEHALF OF THE BOARD OF DIRECTORS
“Peter Laipnieks”
Peter Laipnieks, President & CEO

Contacts:
Big Bear Gold Corp.
Suite 900, 570 Granville Street
Vancouver, BC  V6C 3P1

Investor Relations: (250) 216.5674
Email:  bigbeargold007@gmail.com
Website:www.bigbeargold.com

The TSX Venture Exchange has in no way passed upon the merits of the proposed acquisition and has neither approved nor disapproved the contents of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking information
All statements included in this press release that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements.  Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. In particular, forward-looking information in this press release includes, but is not limited to, statements with respect to satisfactory due diligence, TSXV approval, the payment of costs relating to a NI 43-101 technical report, the assumption and satisfaction of the obligations under the Option Agreement including completion of all outstanding property option payments, the NSR Royalty and buy-back right relating thereto, and the timing and completion of the proposed transactions.  Forward-looking statements are based on the current opinions and expectations of management.  These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances.  In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control.  Actual events or results may differ materially from those projected in the forward-looking statements and the Company cautions against placing undue reliance thereon. 

The Company believes that the expectations reflected in forward-looking statements included herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included herein should not be unduly relied upon.  These statements speak only as of the date hereof.  The Company does not intend, and does not assume any obligation, to revise or update these forward-looking statements, except as required by applicable law.

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader: Investec Bank plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Gamma Communications Plc
(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to Gamma Communications Plc
(d)        Date dealing undertaken: 30th September 2026

(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
        If it is a cash offer or possible cash offer, state “N/A”
N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary shares Purchases 7,399 1122 1122
Ordinary shares Sales 7,500 1122 1122

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
N/A N/A N/A N/A N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

3.        OTHER INFORMATION
        
(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure: 01st October 2026
Contact name: Abhishek Gawde
Telephone number: +91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Strategic Iowa Facility Expected to Leverage Tetra Pak Technology to Scale Prairie Hills Location, Drive Long-Term Growth, Local Economic Incentives and Significant Job Creation to Build Scalable Manufacturing Infrastructure

BELVIDERE, NJ, Oct. 01, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform, today announced that it has entered into a Real Estate Purchase Contract to acquire the Webster City, Iowa property that is being developed as the Company’s Prairie Hills ready-to-drink (“RTD”) manufacturing facility. Under the agreement, Edible Garden will acquire the property from Iowa Shrimp Holdings, LLC which includes the real estate, buildings, and improvements, as well as specified equipment, fixtures and other property associated with the site. Upon completion, the acquisition would transition Edible Garden from tenant to owner of the Prairie Hills property, providing the Company with long-term control over a strategic manufacturing asset that is expected to play a key role in the continued expansion of its Farm-to-Formula® platform.

The acquisition would further align Edible Garden’s ownership of the property with the investments being made to establish Prairie Hills as a scalable RTD manufacturing platform. The facility is being developed to support commercial production across protein, functional wellness, and other clean-label nutrition categories, including both Edible Garden branded products and private-label manufacturing opportunities. The Company’s previously announced plans contemplate large-scale production of shelf-stable nutritional beverages and significant private-label opportunities at the facility.

“Acquiring the Prairie Hills property would represent an important step in the continued development of our Farm-to-Formula® platform,” said Jim Kras, Chief Executive Officer of Edible Garden. “We have been systematically putting the pieces in place to build a scalable RTD and clean nutrition manufacturing platform in Webster City. Moving from tenant to owner would give us greater long-term control over this critical infrastructure and further align the facility with the significant investments we are making in manufacturing capabilities, product development, and commercialization.”

“Our vision for Prairie Hills extends well beyond any single product or customer. We are building a flexible manufacturing platform designed to support clean-label, functional and protein-based beverages on a commercial scale. We believe ownership of the facility would strengthen that platform, provide greater operational flexibility, and establish an important long-term foundation for the development and commercialization of higher-value, shelf-stable nutrition products,” concluded Mr. Kras.

Prairie Hills is designed to extend Edible Garden’s vertically integrated capabilities beyond its established fresh-produce operations and further into value-added consumer products and nutrition. The Company’s Farm-to-Formula® strategy is intended to connect its agricultural expertise and clean-label product development capabilities with formulation, advanced manufacturing, and retail distribution. Edible Garden believes ownership of the Webster City property would provide greater control over an asset central to that strategy while supporting continued investment in the facility and its manufacturing infrastructure.

The transaction includes the real estate, buildings, and improvements, as well as specified equipment, fixtures and other property associated with the site. The acquisition remains subject to customary due diligence and closing conditions, and upon closing, Edible Garden would take possession of the property, with title conveyed to the Company or a wholly owned subsidiary.

ABOUT EDIBLE GARDEN®

Edible Garden AG Incorporated is a leader in controlled environment agriculture (CEA), delivering organic, better-for-you, sustainable produce and products through its Zero-Waste Inspired® next-generation farming model. Available in over 6,000 retail locations across the United States, Caribbean, and South America, Edible Garden is at the forefront of the CEA and sustainability technology movement, distinguished by its advanced safety-in-farming protocols, sustainable packaging, patented GreenThumb software, and innovative Self-Watering in-store displays. The Company operates state-of-the-art, vertically integrated greenhouses and processing facilities, including Edible Garden Heartland in Grand Rapids, Michigan; Edible Garden Prairie Hills in Webster City, Iowa; and its headquarters at Edible Garden Belvidere in New Jersey. It also partners with a network of contract growers strategically located near major U.S. markets to ensure freshness and reduce environmental impact. The Company is also expanding its Prairie Hills facility in Webster City, Iowa, into a dedicated ready-to-drink (RTD) clean nutrition manufacturing hub, supporting its Farm-to-Formula® strategy and its transformation into higher-margin, shelf-stable nutrition categories.

Edible Garden’s proprietary GreenThumb 2.0 software—protected by U.S. Patents US 11,158,006 B1, US 11,410,249 B2, and US 11,830,088 B2—optimizes vertical and traditional greenhouse growing conditions while aiming to reduce food miles. Its patented Self-Watering display (U.S. Patent No. D1,010,365) is designed to extend plant shelf life and elevate in-store presentation. In addition to its core CEA operations, Edible Garden owns three patents in advanced aquaculture technologies: a closed-loop shrimp farming system (US 6,615,767 B1), a modular recirculating aquaculture setup with automated water treatment and feeding (US 10,163,199 B2), and a sensor-driven ammonia control method utilizing electrolytic chlorine generation (US 11,297,809 B1).

The Company has been recognized as a FoodTech 500 firm by Forward Fooding, is a multi-year participant in Walmart’s Project Gigaton and a Giga Guru designee and has received NRG’s Excellence in Energy Award for its commitment to measurable environmental performance and energy stewardship. Edible Garden also develops and markets a growing line of nutrition and specialty food products, including Vitamin Way® and Vitamin Whey®—plant and whey protein powders—and Kick. Sports Nutrition, a premium performance line for health-conscious athletes seeking cleaner, better-for-you options. The Company’s offerings further include fresh, sustainable condiments such as Pulp fermented gourmet and chili-based sauces, as well as Pickle Party, a collection of fermented fresh pickles and krauts.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, without limitation, statements regarding the proposed acquisition of the Prairie Hills property; the timing and completion of the acquisition; the satisfaction of due diligence and closing conditions; the anticipated benefits of owning the property; the development, financing, commissioning and operation of the Prairie Hills facility; the anticipated use of Tetra Pak technology; projected production capacity; the development and commercialization of ready-to-drink, protein, functional wellness and other clean-label nutrition products; anticipated private-label manufacturing opportunities, local economic incentives and job creation; and the expansion of the Company’s Farm-to-Formula® platform. Forward-looking statements may be identified by words such as “may,” “will,” “would,” “could,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “potential,” “continue,” “designed” and similar expressions. Forward-looking statements are based on information currently available to the Company and management’s current plans, assumptions and expectations. They are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially, including the risk that the acquisition may not close on the anticipated terms or timeline, or at all; the failure to satisfy closing conditions; adverse due diligence findings; title, environmental, regulatory or other issues affecting the property; the availability and cost of financing, equipment, technology, labor, utilities and raw materials; construction, installation, permitting, commissioning, supply-chain and production delays or cost overruns; the Company’s ability to successfully operate the facility, achieve anticipated capacity and efficiencies, commercialize products, secure customers and private-label opportunities, obtain anticipated incentives and create expected jobs; market demand and competition; the Company’s liquidity and capital requirements; and the other risks described in the Company’s filings with the Securities and Exchange Commission, including under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes its expectations are reasonable, it cannot guarantee future results, performance or achievements. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statement as a result of new information, future events, changed circumstances or otherwise.

Learn more at https://ediblegardenag.com.
For Pulp products, visit https://www.pulpflavors.com.
For Vitamin Whey® products, visit https://vitaminwhey.com.
For Kick. Sports Nutrition products, visit https://kicksportsnutrition.net/.
Watch the Company’s latest corporate video here.

Investor Contacts:
Crescendo Communications, LLC
212-671-1020
EDBL@crescendo-ir.com

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader: Investec Bank Plc
(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offeree
Advanced Medical Solutions Group Plc
(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc
(d)        Date dealing undertaken: 30th September 2026
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
        If it is a cash offer or possible cash offer, state “N/A”
N/A

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary shares Purchase 153,365 282.02 282
Ordinary shares Sales 302,936 282.25 282

(b)        Cash-settled derivative transactions

Class of relevant security Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit
N/A N/A N/A N/A N/A

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
e.g. American, European etc.
Expiry date Option money paid/ received per unit
N/A N/A N/A N/A N/A N/A N/A N/A

(ii)        Exercise

Class of relevant security Product description
e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit
N/A N/A N/A N/A N/A

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing
e.g. subscription, conversion
Details Price per unit (if applicable)
N/A N/A N/A N/A

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure: 01st October 2026
Contact name: Abhishek Gawde
Telephone number: +91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.